In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response

PLoS ONE - United States
doi 10.1371/journal.pone.0135444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Targeted Desialylation Overcomes Glyco-Immune Checkpoints and Potentiates the Anticancer Immune Response in Vivo

2019English

Antibodies Targeted to TRAIL Receptor-2 and ErbB-2 Synergize in Vivo and Induce an Antitumor Immune Response

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Progress in Targeted Delivery of siRNA to Combat Coxsackievirus

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2011English

Peptide-Functionalized Nanogels for Targeted siRNA Delivery

Bioconjugate Chemistry
Organic ChemistryBiotechnologyPharmacologyPharmaceutical ScienceBioengineeringBiomedical Engineering
2009English

Antibody-Mediated Delivery of Anti-Kras-siRNA in Vivo Overcomes Therapy Resistance in Colon Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Functionalized Selenium Nanoparticles for Targeted siRNA Delivery Silence Derlin1 and Promote Antitumor Efficacy Against Cervical Cancer

Drug Delivery
MedicinePharmaceutical Science
2019English

TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2009English

Polymeric Vector-Mediated Targeted Delivery of Anti-Pak1 siRNA to Macrophages for Efficient Atherosclerosis Treatment

English

Intratracheal Administration of siRNA Triggers mRNA Silencing in Lung to Modulate T Cell Immune Response and Lung Inflammation

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy